Embla Medical hf.
Embla Medical hf. (OSSFF) Revenue
Annual & quarterly revenue history · segment & region breakdown
OSSFF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEmbla Medical hf. trailing twelve-month (TTM) revenue is $0.96B, an increase of 12.72% year-over-year from $0.96B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.96B | +$0.11B | +12.72% |
| 2024-12-31 | $0.85B | +$0.07B | +8.81% |
| 2023-12-31 | $0.79B | +$0.07B | +9.33% |
| 2022-12-31 | $0.72B | -$0.00B | -0.00% |
| 2021-12-31 | $0.72B | +$0.09B | +14.16% |
| 2020-12-31 | $0.63B | -$0.06B | -8.27% |
| 2019-12-31 | $0.69B | +$0.07B | +11.97% |
| 2018-12-31 | $0.61B | +$0.04B | +7.78% |
| 2017-12-31 | $0.57B | +$0.05B | +9.19% |
| 2016-12-31 | $0.52B | +$0.04B | +7.81% |
Compare revenue vs peers
Medical - DevicesCompare OSSFF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Embla Medical hf. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Embla Medical hf. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Embla Medical hf.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
OSSFF revenue · 4 questionsOSSFF's trailing twelve-month (TTM) revenue is $0.96B. That is an increase of 12.72% year-over-year from $0.96B in FY2025.
▸ Source: FMP · Embla Medical hf. SEC filings · GAAP · Embla Medical hf. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026